Stereotactic body radiotherapy results for pulmonary oligometastases: a two-institution collaborative investigation

Y Niibe, H Yamashita, K Sekiguchi… - Anticancer …, 2015 - ar.iiarjournals.org
Aim: The current study investigated outcomes and prognostic factors of pulmonary
oligometastases at two Institutions. Patients and Methods: SBRT (stereotactic body …

[HTML][HTML] How aggressive one need to be in treatment of patients with oligometastasis from non-small cell lung cancer?

JM Noh, YC Ahn - Journal of Thoracic Disease, 2017 - jtd.amegroups.org
The concept of “oligometastases” was first proposed by Hellman and Weichselbaum in 1995
and defined as metastases limited in number and location (1, 2). Though being in blood …

[HTML][HTML] Radiotherapy of Oligometastatic Cancers

F Alongi, S Gaito - Cancers, 2024 - mdpi.com
The enhanced multidisciplinary treatment approach and the widespread use of advanced
imaging techniques have led to an improvement in survival rates, inevitably associated with …

Management of non-small cell lung cancer with oligometastasis

LC Villaruz, GJ Kubicek, MA Socinski - Current oncology reports, 2012 - Springer
Abstract Patients with oligometastatic Non-Small Cell Lung Cancer (NSCLC) present a
potential opportunity for curative therapy; however, the challenge remains the definitive …

[HTML][HTML] Accelerating the development of therapeutic strategy for oligometastasis

Y Shimada - Journal of Thoracic Disease, 2019 - ncbi.nlm.nih.gov
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2019; 11 (12): 5670-5673|
http://dx. doi. org/10.21037/jtd. 2019.12. 42 proved that LAT contributed to favorable long …

The emerging role of local therapy in oligometastatic non–small cell lung cancer

JM Isbell, BT Li, DR Gomez - The Journal of Thoracic and Cardiovascular …, 2022 - jtcvs.org
Feature Editor Introduction—Local therapy for oligometastatic non–small cell lung cancer
(NSCLC) is a complex and controversial topic that continues to evolve. With advances in …

[HTML][HTML] Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review

N Sundahl, Y Lievens - Translational Lung Cancer Research, 2021 - ncbi.nlm.nih.gov
Preclinical and early clinical evidence suggest that radical radiotherapy of oligometastatic
disease in non-small cell lung cancer (NSCLC) patients can impact outcomes with relatively …

PP. 17 Stereotactic Ablative Radiotherapy in Oligometastatic Pulmonary Disease. First Institutional Experience

AG Palacios, C Rios, B Raiden, C Zelada… - Journal of Thoracic …, 2023 - Elsevier
Methods This is a descriptive, retrospective and observational study of 20 patients treated
with SABR at the Centro de Radioterapia Dean Funes from July 2017 to March 2021. With 1 …

[HTML][HTML] Oligometastases: Defined by prognosis and evaluated by cure

H Kaneda, Y Saito - Cancer Treatment Communications, 2015 - Elsevier
Recently, the state of oligometastases has been spotlighted in the treatment strategy for
metastases. Aggressive local treatment for oligometastases, including pulmonary resection …

Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part I: non-small cell lung cancer and breast cancer

A Rodríguez Pérez, E Felip Font, R Chicas-Sett… - Clinical and …, 2023 - Springer
Oligometastatic disease (OMD) defines a cancer status that is intermediate between
localized and widely spread metastatic disease, and can be treated with curative intent …